/ARCOMA.ST
ARCOMA.ST Stock - Arcoma AB
Healthcare|Medical - DevicesSTO
$7.50+5.63%
+$0.40 (+5.63%) • Dec 23
59
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.22
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.96
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $8.25
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for ARCOMA.ST
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$7.42 – $7.58
TARGET (TP)$8.63
STOP LOSS$6.90
RISK/REWARD1:1.9
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta0.61
52W High$11.90
52W Low$6.86
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $156.81M | $163.01M | $125.05M | $117.13M | $117.42M |
| Gross Profit | $62.61M | $57.91M | $50.45M | $41.65M | $45.25M |
| Gross Margin | 39.9% | 35.5% | 40.3% | 35.6% | 38.5% |
| Operating Income | $13.65M | $4.66M | $3.13M | $-7,452,000 | $2.29M |
| Net Income | $11.18M | $2.56M | $1.90M | $-7,473,000 | $1.36M |
| Net Margin | 7.1% | 1.6% | 1.5% | -6.4% | 1.2% |
| EPS | $0.85 | $0.19 | $0.15 | $-0.58 | $0.11 |
Company Overview
Arcoma AB develops, produces, and provides radiology solutions worldwide. It offers digital x-ray and radiography systems for radiographic applications, as well as for use in general, eneral, muscle/skeleton, thoratic, pediatric, and trauma/resus clinics. The company sells its products through OEM partners. Arcoma AB was founded in 1990 and is based in Växjö, Sweden.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
ARCOMA.STBeat Rate
0%
Last 3 quarters
Avg Surprise
-49.4%
EPS vs Estimate
Beats / Misses
0/3
Last 12 quarters
Latest EPS
$0.11
Q4 2025
EPS Surprise History
Q1 24
No data
Q2 24
No data
Q3 24
No data
Q4 24
No data
Q1 25
No data
Q2 25
-22.5%
$0.15vs$0.20
Q3 25
-99.7%
$0.00vs$0.10
Q4 25
-26.1%
$0.11vs$0.15
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2026 | Apr 27, 2026 | — | — | — | — |
Q1 2026 | Feb 11, 2026 | — | — | — | — |
Q4 2025 | Oct 23, 2025 | $0.15 | $0.11 | -26.1% | ✗ MISS |
Q3 2025 | Aug 21, 2025 | $0.10 | $0.00 | -99.7% | ✗ MISS |
Q2 2025 | Apr 29, 2025 | $0.20 | $0.15 | -22.5% | ✗ MISS |
Q1 2025 | Feb 13, 2025 | — | $0.05 | — | — |
Q4 2024 | Oct 24, 2024 | — | $0.17 | — | — |
Q3 2024 | Aug 15, 2024 | — | $0.27 | — | — |
Q2 2024 | Apr 25, 2024 | — | $0.34 | — | — |
Q1 2024 | Jan 29, 2024 | — | $0.19 | — | — |
Q4 2023 | Oct 26, 2023 | — | $0.15 | — | — |
Q3 2023 | Aug 17, 2023 | — | $0.03 | — | — |
Q2 2023 | Apr 27, 2023 | — | $-0.21 | — | — |
Q1 2023 | Feb 9, 2023 | — | $0.02 | — | — |
Q4 2022 | Oct 27, 2022 | — | $0.11 | — | — |
Q3 2022 | Aug 17, 2022 | — | $0.08 | — | — |
Q2 2022 | Apr 28, 2022 | — | $-0.11 | — | — |
Q1 2022 | Feb 10, 2022 | — | $-0.56 | — | — |
Q4 2021 | Oct 28, 2021 | — | $-0.24 | — | — |
Q3 2021 | Aug 25, 2021 | — | $0.08 | — | — |
Latest News
Loading news...
Frequently Asked Questions about ARCOMA.ST
What is ARCOMA.ST's current stock price?
Arcoma AB (ARCOMA.ST) is currently trading at $7.50 per share. The stock has moved +5.63% today.
What is the analyst price target for ARCOMA.ST?
No analyst price targets are currently available for this stock.
What sector is Arcoma AB in?
Arcoma AB operates in the Healthcare sector, specifically within the Medical - Devices industry. The company is traded on the STO exchange.
What is ARCOMA.ST's market cap?
Arcoma AB has a market capitalization of $0.11 billion, making it a small-cap company.
Does ARCOMA.ST pay dividends?
No, Arcoma AB does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorBIOSGN.ST
Biosergen AB
$42.60
Mkt Cap: $0.1B
BIOVIC-B.ST
Biovica International AB (publ)
$0.34
Mkt Cap: $0.1B
BRAIN.ST
BrainCool AB (publ)
$0.58
Mkt Cap: $0.1B
ICO.ST
Iconovo AB (publ)
$1.14
Mkt Cap: $0.1B
LXB.ST
Luxbright AB (publ)
$0.45
Mkt Cap: $0.1B
NEOLA.ST
Neola Medical AB (publ)
$1.11
Mkt Cap: $0.1B
NICA.ST
Nanologica AB (publ)
$0.71
Mkt Cap: $0.1B
SCIB.ST
SciBase Holding AB (publ)
$0.36
Mkt Cap: $0.1B
SPEC.ST
SpectraCure AB (publ)
$0.16
Mkt Cap: $0.1B
VIVE.ST
Vivesto AB
$0.14
Mkt Cap: $0.1B
Explore stocks similar to ARCOMA.ST for comparison